Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
DPP4, MERP-1 and their roles in macrophage polarization and atherosclerosis
EF 2021-22
Résumé
Atherosclerosis
is a slow-developing disease of the artery wall, causing the hardening and
closing of the blood vessel and negatively affecting cardiac function. It
develops over decades without symptoms and is a leading cause of death in
North America. Immune cells called macrophages are important in the growth
and prevention of atherosclerosis. Dipeptidyl peptidase 4 (DPP4) is a
protein that acts like molecular scissors to clip and regulate signals in
the body. We have discovered that DPP4 can clip a portion of the protein
mammalian ependymin related protein-1 (MERP-1) which may have a negative
impact on atherosclerosis. We have seen that DPP4 is expressed in
macrophages which accelerate atherosclerosis. On the other hand, MERP-1 is
expressed by macrophages when atherosclerosis is slower. To understand
what these proteins do in macrophages and atherosclerosis, we will delete
the expression of both DPP4 or MERP-1 and follow the development of
atherosclerosis. We will also measure the ability of the macrophages to
enter the arteries, engulf the proteins and fats which close the vessel
and remove them. This will help us understand if DPP4 and MERP-1 are
important in the development of this disease and if we can use these as
indicators of atherosclerosis.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
474336
Name
Clement Andrew
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
DPP4, MERP-1 and their roles in macrophage polarization and atherosclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bmdm; Atherosclerosis; Bone Marrow-Derived Macrophages; Cardiovascular Disease; Cd26; Dpp4; Epdr1; Macrophage; Merp-1
Abstract
<html>
<head>
</head>
<body>
<span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none"><font color="rgb(0, 0, 0)" face="Verdana, Arial, Helvetica, sans-serif" size="12.8px">Atherosclerosis
is a slow-developing disease of the artery wall, causing the hardening and
closing of the blood vessel and negatively affecting cardiac function. It
develops over decades without symptoms and is a leading cause of death in
North America. Immune cells called macrophages are important in the growth
and prevention of atherosclerosis. Dipeptidyl peptidase 4 (DPP4) is a
protein that acts like molecular scissors to clip and regulate signals in
the body. We have discovered that DPP4 can clip a portion of the protein
mammalian ependymin related protein-1 (MERP-1) which may have a negative
impact on atherosclerosis. We have seen that DPP4 is expressed in
macrophages which accelerate atherosclerosis. On the other hand, MERP-1 is
expressed by macrophages when atherosclerosis is slower. To understand
what these proteins do in macrophages and atherosclerosis, we will delete
the expression of both DPP4 or MERP-1 and follow the development of
atherosclerosis. We will also measure the ability of the macrophages to
enter the arteries, engulf the proteins and fats which close the vessel
and remove them. This will help us understand if DPP4 and MERP-1 are
important in the development of this disease and if we can use these as
indicators of atherosclerosis.</font></span>
</body>
</html>
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Clement, Andrew
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~